__timestamp | Perrigo Company plc | Walgreens Boots Alliance, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 2613100000 | 54823000000 |
Thursday, January 1, 2015 | 2891500000 | 76691000000 |
Friday, January 1, 2016 | 3228800000 | 87477000000 |
Sunday, January 1, 2017 | 2966700000 | 89052000000 |
Monday, January 1, 2018 | 2900200000 | 100745000000 |
Tuesday, January 1, 2019 | 3064100000 | 91915000000 |
Wednesday, January 1, 2020 | 3248100000 | 95905000000 |
Friday, January 1, 2021 | 2722500000 | 104442000000 |
Saturday, January 1, 2022 | 2996200000 | 104437000000 |
Sunday, January 1, 2023 | 2975200000 | 112009000000 |
Monday, January 1, 2024 | 121134000000 |
In pursuit of knowledge
In the ever-evolving landscape of the pharmaceutical industry, understanding cost dynamics is crucial. From 2014 to 2023, Walgreens Boots Alliance, Inc. consistently outpaced Perrigo Company plc in terms of cost of revenue. Walgreens' cost of revenue surged by approximately 104% over this period, peaking at an impressive $112 billion in 2023. In contrast, Perrigo's cost of revenue remained relatively stable, fluctuating around $3 billion annually, with a slight increase of about 14% over the same period.
This disparity highlights Walgreens' expansive operations and market reach compared to Perrigo's more focused approach. The data for 2024 is incomplete, but Walgreens' trajectory suggests continued growth. Investors and industry analysts should consider these trends when evaluating the financial health and strategic positioning of these companies.
Cost of Revenue: Key Insights for Sanofi and Walgreens Boots Alliance, Inc.
Analyzing Cost of Revenue: Bristol-Myers Squibb Company and Perrigo Company plc
Cost of Revenue Comparison: BeiGene, Ltd. vs Perrigo Company plc
Cost of Revenue: Key Insights for United Therapeutics Corporation and Walgreens Boots Alliance, Inc.
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Perrigo Company plc
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Perrigo Company plc
Walgreens Boots Alliance, Inc. vs Geron Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Viridian Therapeutics, Inc.
Lantheus Holdings, Inc. vs Perrigo Company plc: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Perrigo Company plc's Expenses
Cost Insights: Breaking Down Alkermes plc and Perrigo Company plc's Expenses
Cost of Revenue Trends: Perrigo Company plc vs Wave Life Sciences Ltd.